---
type: "Evidence Item"
title: "Investing in Merge Labs"
description: "OpenAI is investing in Merge Labs to support new brain computer interfaces that bridge biological and artificial intelligence to maximize human ability, agency, and experience."
resource: "https://openai.com/index/investing-in-merge-labs"
tags: ["appendix-iii", "vendor", "openai"]
timestamp: "2026-01-15"
category: "vendor"
publisher: "OpenAI"
cope_score: 64
confidence: 0.9
---

# Investing in Merge Labs

# Claim

OpenAI is investing in Merge Labs to support new brain computer interfaces that bridge biological and artificial intelligence to maximize human ability, agency, and experience.

# Relevance

Appendix III, section two: vendor threshold and platform capability evidence

# Oracle Verdict

This is a lower-to-mid strength vendor signal for the capability register. It does not prove displacement on its own, but it records another platform step that can later show up as workflow automation, procurement change, or organisational dependency.

# Metadata

* Publisher: OpenAI
* Category: vendor
* Sector: Customer operations
* Capability: Vendor platform capability signal
* Cope score: 64
* Confidence: 0.9

# Related Concepts

* [Live evidence index](index.md)
* [Thesis](../thesis.md)

# Citations

[1] [Investing in Merge Labs](https://openai.com/index/investing-in-merge-labs)